The influence of JNK inhibitor on hemodynamics after ischemia/reperfusion injury to the heart in rats

OBJECTIVE: To investigate the effect and mechanism of JNK mitogen-activated protein kinases (JNK MAPKs) inhibitor SP 600125 on hemodynamics after ischemia/reperfusion (I/R) injury to heart in anesthetized rats

Bibliographische Detailangaben
Veröffentlicht in:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue. - 1998. - 20(2008), 12 vom: 29. Dez., Seite 727-9
1. Verfasser: Qian, Hong-Jin (VerfasserIn)
Weitere Verfasser: Li, Zhi-Liang, Jiao, Bao-Ming, Zheng, Jian-Sheng, Su, Lei
Format: Aufsatz
Sprache:Chinese
Veröffentlicht: 2008
Zugriff auf das übergeordnete Werk:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Anthracenes Protein Kinase Inhibitors Pyrazines pyrazolanthrone 1TW30Y2766 JNK Mitogen-Activated Protein Kinases EC 2.7.11.24 tetramethylpyrazine V80F4IA5XG
LEADER 01000caa a22002652 4500
001 NLM185441815
003 DE-627
005 20250210014213.0
007 tu
008 231223s2008 xx ||||| 00| ||chi c
028 5 2 |a pubmed25n0618.xml 
035 |a (DE-627)NLM185441815 
035 |a (NLM)19111119 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Qian, Hong-Jin  |e verfasserin  |4 aut 
245 1 4 |a The influence of JNK inhibitor on hemodynamics after ischemia/reperfusion injury to the heart in rats 
264 1 |c 2008 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 09.03.2010 
500 |a Date Revised 24.11.2016 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a OBJECTIVE: To investigate the effect and mechanism of JNK mitogen-activated protein kinases (JNK MAPKs) inhibitor SP 600125 on hemodynamics after ischemia/reperfusion (I/R) injury to heart in anesthetized rats 
520 |a METHODS: Thirty-six healthy adult Sprague-Dawley (SD) rats were randomly divided into six groups (each n=6): sham operation (SO) group, I/R group, three JNK inhibitor groups (model groups) and ligustrazine hydrochloride (LH) group. In the SO group, a silk suture was passed underneath a main branch of the left coronary artery without tying. In the rest groups, the left coronary artery was occluded lasting for 30 minutes followed by reperfusion for 180 minutes. In the model groups, SP 600125 was intravenously administered 5 minutes before the end of the ischemia period, and continued during reperfusion period with a total dose of 4.7, 14.4 and 47.9 mg/kg respectively. Control animals received normal saline or LH 30 mg/kg in the same manner. The changes in hemodynamics, including heart rate (HR), mean blood pressure (MBP), maximal change rate of intraventricular pressure rise/down (+/-dp/dt max),left ventricular systolic pressure (LVSP), LVDP' [LVDP'=LVSP-left ventricular diastolic pressure (LVDP)], left ventricular end-diastolic pressure (LVEDP), were determined during I/R 
520 |a RESULTS: There was no statistical difference in hemodynamics among the groups before occluding. The values of HR, MAP, +/-dp/dt max, LVSP, LVDP' in I/R group were significantly lower than those in SO group, and LVEDP was significantly higher. Compared with I/R group, +/-dp/dt max, LVSP, LVDP' in model groups and LH group were significantly higher (P<0.05 or P<0.01). There was no significant change in HR, MBP and LVEDP after the administration of JNK inhibitor or LH 
520 |a CONCLUSION: Both JNK inhibitor and LH ameliorate cardiac systolic and diastolic dysfunction induced by I/R, without influence on MBP and HR in anesthetized rats 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Anthracenes  |2 NLM 
650 7 |a Protein Kinase Inhibitors  |2 NLM 
650 7 |a Pyrazines  |2 NLM 
650 7 |a pyrazolanthrone  |2 NLM 
650 7 |a 1TW30Y2766  |2 NLM 
650 7 |a JNK Mitogen-Activated Protein Kinases  |2 NLM 
650 7 |a EC 2.7.11.24  |2 NLM 
650 7 |a tetramethylpyrazine  |2 NLM 
650 7 |a V80F4IA5XG  |2 NLM 
700 1 |a Li, Zhi-Liang  |e verfasserin  |4 aut 
700 1 |a Jiao, Bao-Ming  |e verfasserin  |4 aut 
700 1 |a Zheng, Jian-Sheng  |e verfasserin  |4 aut 
700 1 |a Su, Lei  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue  |d 1998  |g 20(2008), 12 vom: 29. Dez., Seite 727-9  |w (DE-627)NLM098227793  |x 1003-0603  |7 nnns 
773 1 8 |g volume:20  |g year:2008  |g number:12  |g day:29  |g month:12  |g pages:727-9 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 20  |j 2008  |e 12  |b 29  |c 12  |h 727-9